drugset / Trial / NCT00685698

Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections

NCT00685698

Phase 2 Completed 40 enrolled TaiGen Biotechnology Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections

Timeline

Start
2008-06
Primary completion
2009-04
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Nemonoxacin Small molecule 750 mg Oral

Indications

No indication recorded.